Receipt of a significant purchase order by the Issuer’s subsidiary
The Management Board of Selvita S.A. with its registered office in Krakow (“Issuer”, “Selvita”) hereby announces that on January 18, 2022 the Issuer’s subsidiary – Ardigen S.A. with its registered office in Krakow (“Ardigen”) has received a purchase order with a total value of EUR 1.191.967,00 (PLN 5.387.810,04 converted at the rate EUR 1 = PLN 4,5201) under a framework agreement executed on February 19, 2018 between Ardigen and one of the largest pharmaceutical companies with its registered office in Germany (“Customer”).
The subject of the purchase order is to enhance the Customer’s computational biology and digital sciences operations, among others by supporting digital transformation processes of gathering, processing, accessing, analyzing, visualizing and interpreting data (mostly by using AI) to speed up strategic development projects.
Ardigen’s cooperation with the Customer has been ongoing since 2018, and the Issuer informed about the previous extension of cooperation with the Customer in the current report No. 39/2020 dated December 18, 2020. Considering the value of the purchase order, the Issuer’s Management Board considers the received purchase order to be significant for the implementation of Selvita Group’s long-term plans and further development of Ardigen’s activities.
Legal basis: Art. 17.1 of MAR
Representatives of the Company:
• Bogusław Sieczkowski – President of the Management Board
• Dawid Radziszewski – Management Board Member